breast cancer
New Strategy Proposed for HR+, HER2– Advanced Breast Cancer
In certain patients with HR+, HER2– advanced breast cancer, switching from an aromatase inhibitor to ...
AUGUST 27, 2025
First and Only Ready-to-Dilute, Multi-Dose Vial of Thiotepa Approved
The FDA has granted approval for the 100 mg/10 mL multi-dose vial of Tepylute, a ready-to-dilute formulation of ...
MAY 8, 2025
Rise in Breast Cancer Among Young Women Requires New Models of Care
The incidence of young women with breast cancer is steadily increasing, and supportive care programs can empower ...
APRIL 9, 2025
FDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast Cancer
The FDA has approved Datroway for adult patients with unresectable or metastatic, HR-positive, HER2-negative ...
JANUARY 22, 2025
Kisqali With an AI and Kisqali Femara Co-Pack Approved for Early High-Risk Breast Cancer
The FDA has approved Kisqali with an aromatase inhibitor for the adjuvant treatment of adults with HR-positive, ...
SEPTEMBER 17, 2024
Sexual Dysfunction Common for Women With MBC
Self-reported sexual dysfunction is frequent in women with metastatic breast cancer, according to a recent study ...
JUNE 21, 2024
FDA Approves First Interchangeable Biosimilars to Xgeva and Prolia
The FDA approved the first interchangeable biosimilar to Prolia and Xgeva.
MARCH 7, 2024
Empathy Promotes Psychological Well-Being in Breast Cancer Patients
Clinicians who show more empathy promote better psychological health among breast cancer patients, according to a ...
DECEMBER 7, 2023
Datopotamab Deruxtecan Shines in Metastatic Breast Cancer
In patients with inoperable or metastatic hormone receptor–positive (HR-positive), HER2-negative breast ...
NOVEMBER 22, 2023
Patients With HER2-Low Early Breast Cancer Respond to Trastuzumab Deruxtecan
Neoadjuvant trastuzumab deruxtecan (T-DXd) (Enhertu, Daiichi Sankyo) produced responses and decreased HER2 ...
JANUARY 13, 2023
Hot Flashes May Predict Worse Outcomes for ER-Positive Breast Cancer
Research has shown adjuvant hormone therapy can greatly improve disease-free survival in patients with estrogen ...
SEPTEMBER 30, 2022
New Options for Patients With Early-Stage Breast Cancer
Multiple recent advances in the management of early-stage breast cancer include updates to treatment options and ...
MAY 18, 2022
